Literature DB >> 23610204

Warts transmitted in families and schools: a prospective cohort.

Sjoerd C Bruggink1, Just A H Eekhof, Paulette F Egberts, Sophie C E van Blijswijk, Willem J J Assendelft, Jacobijn Gussekloo.   

Abstract

BACKGROUND AND
OBJECTIVE: Cutaneous warts are common in primary schoolchildren; however, knowledge on the routes of transmission of human papillomavirus (HPV) causing warts is scarce. This study examines the association between the degree of HPV exposure and incidence of warts in primary schoolchildren to support evidence-based recommendations on wart prevention.
METHODS: In this prospective cohort study, the hands and feet of all children in grades 1 to 7 (aged 4-12 years) of 3 Dutch primary schools were inspected for the presence of warts at baseline and after 11 to 18 months of follow-up. Data on the degree of HPV exposure included information obtained from parental questionnaires: preexistent warts, warts in family, prevalence of warts at baseline in the class, and use of public places (eg, swimming pools).
RESULTS: Of the 1134 eligible children, 97% participated; the response rate from parental questionnaires was 77%, and loss to follow-up was 9%. The incidence for developing warts was 29 per 100 person-years at risk (95% confidence interval [CI] 26-32). Children with a white skin type had an increased risk of developing warts (hazard ratio [HR] 2.3, 95% CI 1.3-3.9). Having family members with warts (HR 2.08, 95% CI 1.52-2.86) and wart prevalence in the class (HR 1.20 per 10% increase, 95% CI 1.03-1.41) were independent environmental risk factors.
CONCLUSIONS: The degree of HPV exposure in the family and school class contributes to the development of warts in schoolchildren. Preventive recommendations should focus more on limiting HPV transmission in families and school classes, rather than in public places.

Entities:  

Keywords:  cohort study; human papillomavirus; incidence; schoolchildren; transmission; warts

Mesh:

Year:  2013        PMID: 23610204     DOI: 10.1542/peds.2012-2946

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  8 in total

1.  What works best for nongenital warts?

Authors:  Caitlin Finley; Christina Korownyk; Michael R Kolber
Journal:  Can Fam Physician       Date:  2016-12       Impact factor: 3.275

2.  Awareness of human papillomavirus and factors associated with intention to obtain HPV vaccination among Korean youth: quasi experimental study.

Authors:  Hae Won Kim
Journal:  BMC Int Health Hum Rights       Date:  2015-02-21

3.  Long-term safety assessment in children who received hydrolyzed protein formulas with Lactobacillus rhamnosus GG: a 5-year follow-up.

Authors:  Dmf Scalabrin; C Harris; W H Johnston; C L Berseth
Journal:  Eur J Pediatr       Date:  2016-12-15       Impact factor: 3.183

4.  Comparative Clinical Efficacy between Electrodesiccation with Curettage and Application of 80% Phenol Solution in Treatment of Common Warts.

Authors:  Dina Arwina Dalimunthe; Remenda Siregar; Chairiyah Tanjung
Journal:  Open Access Maced J Med Sci       Date:  2018-02-11

5.  Verrucae pedis in children with juvenile idiopathic arthritis and other paediatric rheumatic diseases: a cross-sectional study.

Authors:  Jill Ferrari
Journal:  J Foot Ankle Res       Date:  2022-04-21       Impact factor: 3.050

6.  HPV type-specific distribution among family members and linen in households of cutaneous wart patients.

Authors:  E Ghorzang; M N C de Koning; J N Bouwes Bavinck; J Gussekloo; K D Quint; J J Goeman; M C W Feltkamp; S C Bruggink; J A H Eekhof
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-10-02       Impact factor: 9.228

Review 7.  Common skin problems in children.

Authors:  Gomathy Sethuraman; Neetu Bhari
Journal:  Indian J Pediatr       Date:  2013-12-22       Impact factor: 5.319

8.  The Application of Machine Learning in Predicting Outcome of Cryotherapy and Immunotherapy for Wart Removal.

Authors:  Yashik Singh
Journal:  Ann Dermatol       Date:  2021-07-01       Impact factor: 1.444

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.